Editöre Mektup
BibTex RIS Kaynak Göster
Yıl 2020, Cilt: 2 Sayı: 1, 3 - 5, 23.04.2020

Öz

Kaynakça

  • 1. https://www.who.int/health-topics/coronavirus
  • 2. Su S, Wong G, Shi W, et al. Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trends Microbiol 2016; 24: 490-502.
  • 3. Cui J, Li F, Shi ZL. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol 2019; 17: 181-92.
  • 4. WHO Novel Coronavirus (2019-nCoV)Situation Report -1 21 January 2020.
  • 5. https://experience.arcgis.com/experience/685d0ace521648f8a5beeeee1b9125cd
  • 6. Su S, Wong G, Shi W, et al. Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trends Microbiol 2016; 24: 490-502.
  • 7. Cui J, Li F, Shi ZL. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol 2019; 17: 181-92.
  • 8. Peiris JSM, Yuen KY, Osterhaus ADME, et al. Thesevere acute respiratory syndrome. N Engl J Med 2003;349:2431–41.
  • 9. Killerby ME, Biggs HM, Midgley CM, et al. Middle East respiratory syndrome coronavirus transmission. Emerg Infect Dis 2020;26:191–8.
  • 10. WHO, What are the symptoms of COVID-19? https://www.who.int/news-room/q-a-detail/q-a-coronaviruses
  • 11. www.thelancet.com/respiratory Published online February 13, 2020 https://doi.org/10.1016/S2213-2600(20)30071-0
  • 12. Otter JA, Donskey C, Yezli S, et al. Transmission of SARS and MERS coronaviruses and influenza virus in healthcare settings: the possible role of dry surface contamination. J Hosp Infect 2016;92:235–50.
  • 13. WHO. How does COVID-19 spread? https://www.who.int/news-room/q-a-detail/q-a-coronaviruses
  • 14. Belser JA, Rota PA, Tumpey TM. Ocular tropism of respiratory viruses. Microbiol Mol Biol Rev 2013;77:144–56.
  • 15. Arabi YM, Balkhy HH, Hayden FG, et al. Middle East respiratory syndrome. N Engl J Med 2017;376:584–94.
  • 16. Yuen KSC, Chan W-M, Fan DSP, et al. Ocular screening in severe acute respiratory syndrome. Am J Ophthalmol 2004;137:773–4.
  • 17. Loon S-C, Teoh SCB, Oon LLE, et al. The severe acute respiratory syndrome coronavirus in tears. Br J Ophthalmol 2004;88:861–3.
  • 18. Van der Hoek L, Pyrc K, Jebbink MF, et al. Identification of a new human coronavirus. Nat Med. 2004;10:368–73.
  • 19. Li J-PO, Lam DSC, Chen Y, et al. Br J Ophthalmol 2020;104:297–298.
  • 20. WHO. https://www.who.int/docs/default-source/coronaviruse/who-rights-roles-respon-hw-covid-19.pdf?sfvrsn=bcabd401_0

THE LATEST PANDEMIC: COVİD-19 & EYE

Yıl 2020, Cilt: 2 Sayı: 1, 3 - 5, 23.04.2020

Öz

Coronaviruses (CoV) are a large family of viruses that cause illness ranging from the common cold to more severe diseases such as Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV). A novel coronavirus (nCoV) is a new strain that has not been previously identified in humans. Coronaviruses are zoonotic, meaning they are transmitted between animals and people. Detailed investigations found that SARS-CoV was transmitted from civet cats to humans and MERS-CoV from dromedary camels to humans. Several known coronaviruses are circulating in animals that have not yet infected humans. Common signs of infection include respiratory symptoms, fever, cough, shortness of breath and breathing difficulties. In more severe cases, infection can cause pneumonia, severe acute respiratory syndrome, kidney failure and even death(1).

Kaynakça

  • 1. https://www.who.int/health-topics/coronavirus
  • 2. Su S, Wong G, Shi W, et al. Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trends Microbiol 2016; 24: 490-502.
  • 3. Cui J, Li F, Shi ZL. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol 2019; 17: 181-92.
  • 4. WHO Novel Coronavirus (2019-nCoV)Situation Report -1 21 January 2020.
  • 5. https://experience.arcgis.com/experience/685d0ace521648f8a5beeeee1b9125cd
  • 6. Su S, Wong G, Shi W, et al. Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trends Microbiol 2016; 24: 490-502.
  • 7. Cui J, Li F, Shi ZL. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol 2019; 17: 181-92.
  • 8. Peiris JSM, Yuen KY, Osterhaus ADME, et al. Thesevere acute respiratory syndrome. N Engl J Med 2003;349:2431–41.
  • 9. Killerby ME, Biggs HM, Midgley CM, et al. Middle East respiratory syndrome coronavirus transmission. Emerg Infect Dis 2020;26:191–8.
  • 10. WHO, What are the symptoms of COVID-19? https://www.who.int/news-room/q-a-detail/q-a-coronaviruses
  • 11. www.thelancet.com/respiratory Published online February 13, 2020 https://doi.org/10.1016/S2213-2600(20)30071-0
  • 12. Otter JA, Donskey C, Yezli S, et al. Transmission of SARS and MERS coronaviruses and influenza virus in healthcare settings: the possible role of dry surface contamination. J Hosp Infect 2016;92:235–50.
  • 13. WHO. How does COVID-19 spread? https://www.who.int/news-room/q-a-detail/q-a-coronaviruses
  • 14. Belser JA, Rota PA, Tumpey TM. Ocular tropism of respiratory viruses. Microbiol Mol Biol Rev 2013;77:144–56.
  • 15. Arabi YM, Balkhy HH, Hayden FG, et al. Middle East respiratory syndrome. N Engl J Med 2017;376:584–94.
  • 16. Yuen KSC, Chan W-M, Fan DSP, et al. Ocular screening in severe acute respiratory syndrome. Am J Ophthalmol 2004;137:773–4.
  • 17. Loon S-C, Teoh SCB, Oon LLE, et al. The severe acute respiratory syndrome coronavirus in tears. Br J Ophthalmol 2004;88:861–3.
  • 18. Van der Hoek L, Pyrc K, Jebbink MF, et al. Identification of a new human coronavirus. Nat Med. 2004;10:368–73.
  • 19. Li J-PO, Lam DSC, Chen Y, et al. Br J Ophthalmol 2020;104:297–298.
  • 20. WHO. https://www.who.int/docs/default-source/coronaviruse/who-rights-roles-respon-hw-covid-19.pdf?sfvrsn=bcabd401_0
Toplam 20 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Göz Hastalıkları
Bölüm Letter to The Editor
Yazarlar

Erdal Yüzbaşıoğlu

Yayımlanma Tarihi 23 Nisan 2020
Kabul Tarihi 25 Mart 2020
Yayımlandığı Sayı Yıl 2020 Cilt: 2 Sayı: 1

Kaynak Göster

APA Yüzbaşıoğlu, E. (2020). THE LATEST PANDEMIC: COVİD-19 & EYE. Clinical and Experimental Ocular Trauma and Infection, 2(1), 3-5.
AMA Yüzbaşıoğlu E. THE LATEST PANDEMIC: COVİD-19 & EYE. CEOTI. Nisan 2020;2(1):3-5.
Chicago Yüzbaşıoğlu, Erdal. “THE LATEST PANDEMIC: COVİD-19 & EYE”. Clinical and Experimental Ocular Trauma and Infection 2, sy. 1 (Nisan 2020): 3-5.
EndNote Yüzbaşıoğlu E (01 Nisan 2020) THE LATEST PANDEMIC: COVİD-19 & EYE. Clinical and Experimental Ocular Trauma and Infection 2 1 3–5.
IEEE E. Yüzbaşıoğlu, “THE LATEST PANDEMIC: COVİD-19 & EYE”, CEOTI, c. 2, sy. 1, ss. 3–5, 2020.
ISNAD Yüzbaşıoğlu, Erdal. “THE LATEST PANDEMIC: COVİD-19 & EYE”. Clinical and Experimental Ocular Trauma and Infection 2/1 (Nisan 2020), 3-5.
JAMA Yüzbaşıoğlu E. THE LATEST PANDEMIC: COVİD-19 & EYE. CEOTI. 2020;2:3–5.
MLA Yüzbaşıoğlu, Erdal. “THE LATEST PANDEMIC: COVİD-19 & EYE”. Clinical and Experimental Ocular Trauma and Infection, c. 2, sy. 1, 2020, ss. 3-5.
Vancouver Yüzbaşıoğlu E. THE LATEST PANDEMIC: COVİD-19 & EYE. CEOTI. 2020;2(1):3-5.